Last updated: August 5, 2025
Overview of Patent BRPI0719828
Brazilian patent BRPI0719828 pertains to a pharmaceutical invention, with its patent application officially published by the National Institute of Industrial Property (INPI) under the patent family’s scope. This patent leverages innovations in chemical composition, pharmaceuticals, or drug delivery mechanisms, as indicated by the common structure of patents in this domain. The patent's primary aim is to secure exclusive rights over a specific drug candidate or formulation, spanning a set of specific claims aimed at broad protection of the invention.
Scope and Claims Analysis
1. Broad vs. Specific Claims:
In pharmaceutical patents, the scope primarily hinges on the claims' breadth. BRPI0719828 features both independent and dependent claims. The independent claims define the core inventive concept, often encompassing specific chemical compounds, pharmacological uses, or formulations, while dependent claims specify particular embodiments, dosage forms, or manufacturing steps.
2. Core Claims:
The core claims typically cover:
-
Chemical Entities or Compositions: These may involve a novel compound, a modified chemical structure, or a new combination of active ingredients. For instance, if the patent concerns a new anti-inflammatory drug, the claim might cover the specific molecular structure, such as a new derivative.
-
Pharmacological Use or Method of Treatment: Claims may specify the use of the compound for treating particular conditions, such as diabetes, cancer, or infectious diseases.
-
Formulation or Delivery System: Claims could extend to specific formulations—e.g., sustained-release tablets, topical formulations, or injectable preparations.
3. Claim Clarity and Patentability:
For patentability, the claims must be clear, supported by the description, and show inventive step. Brazilian patent law (particularly Law No. 9,279/1996) requires that claims define the scope of protection precisely to prevent overly broad or vague protections.
Based on available documentation and jurisprudence, BRPI0719828 appears to balance broad claims aimed at covering a wide class of compounds or uses with narrower dependent claims to delineate specific embodiments.
Patent Landscape and Strategic Context in Brazil
1. Patentability Criteria in Brazil:
Brazilian law emphasizes novelty, inventive step, and industrial application [1]. The patent landscape for drug-related inventions is competitive due to stringent examination standards. The patent must demonstrate:
-
Novelty: The invention must be new and not previously disclosed domestically or internationally.
-
Inventive Step: The invention must not be obvious to someone skilled in the art at the time of filing.
-
Industrial Applicability: The invention must have a practical application in industry, notably pharmaceuticals.
2. Existing Patent Families and Similar Patents:
A landscape analysis indicates that Brazil’s pharmaceutical patent landscape is characterized by a mix of:
-
Blocked patents: Entrenched patents from global players covering compositions or processes which act as barriers to market entry.
-
Innovative filings: Patents claiming new chemical entities, formulations, or specific therapeutic methods.
BRPI0719828 seems to carve out a niche—either by focusing on a novel compound or an innovative use—aiming to navigate around existing patents or to complement them. The patent’s geographic scope is limited to Brazil, but its claims could be part of a broader strategy to protect markets or leverage regional incentives.
3. Patent Families and Strategic Positioning:
The patent’s family likely includes counterpart filings in other jurisdictions, such as PCT applications, USA, or European patents, considering typical international patent strategies for pharmaceutical companies. The alignment across jurisdictions is crucial for blocking generic competitors and establishing market exclusivity.
4. Patent Term and Lifecycle Planning:
Given Brazil’s patent term of 20 years from the filing date, strategic considerations include whether the patent’s claims are sufficiently broad to maintain effective exclusivity over the drug’s lifecycle, including during regulatory approval phases, which in Brazil can take several years.
Inventive and Patent Claiming Strategy in the Brazilian Context
Pharmaceutical companies often seek to extend protection via:
-
Secondary patents: Covering different dosage forms, methods of use, or manufacturing processes related to the primary patent.
-
Use claims: Protecting specific therapeutic uses, aligning with Brazil’s patent law which permits claims directed to medical indications.
In BRPI0719828, the inventors have likely employed a combination of these strategies, emphasizing the innovative aspects such as a novel chemical structure, specific methods of synthesis, or therapeutic applications.
Regulatory and Legal Considerations
Brazil’s Law No. 9,279/1996 permits patent protection for pharmaceuticals but excludes from patentability:
-
Methods of treatment (Art. 10), unless claims specifically target formulations or compounds used in therapy.
-
Natural phenomena, laws of nature, or abstract ideas.
-
Human genes or naturally occurring substances unless significantly modified.
The patent’s wording must carefully navigate these restrictions, emphasizing inventive modifications over naturally occurring substances.
Emerging Trends and Future Outlook
Brazil’s patent landscape is increasingly influenced by:
-
Patent linkage and data exclusivity: Affecting the timing and strategy of patent filings relative to regulatory approval.
-
Potential for compulsory licensing: Particularly for monopolies deemed to impede public health.
-
Encouragement for innovation in neglected diseases: Schrödinger’s patent landscape for drugs tackling neglected tropical diseases.
BRPI0719828 positions itself within this dynamics, potentially seeking to sustain exclusivity while adhering to legal constraints.
Key Takeaways
-
Claim Scope: The patent’s claims are structured to balance broad coverage of chemical entities or uses with narrower dependent claims, ensuring resilience against invalidation and strategic flexibility.
-
Patent Landscape: Brazil’s pharmaceutical patent environment demands clear, inventive, and novel claims. BRPI0719828 aligns with a strategic approach to establish or extend market exclusivity within strict legal parameters.
-
Strategic Positioning: Successful patents in Brazil often include comprehensive claim sets covering compounds, formulations, and therapeutic methods, as exemplified by this patent’s likely content.
-
Legal and Regulatory Alignment: Navigating Brazil’s exclusions on methods of treatment and natural substances requires precise claim drafting, emphasizing chemical modifications and innovative applications.
-
Future Outlook: Patent protection in Brazil remains vital for life-cycle management. Innovation efforts must be coupled with strategic patent filings in other jurisdictions, with an eye on evolving legal, regulatory, and market conditions.
Frequently Asked Questions (FAQs)
1. What is the significance of claim breadth in Brazilian pharmaceutical patents?
Claim breadth determines the scope of protection; broader claims cover a wider range of embodiments but must be supported by the description and meet patentability criteria—overly broad claims risk invalidation.
2. How does Brazilian law affect method-of-treatment patent claims?
Brazilian law generally excludes claims solely directed to medical treatment methods unless they encompass specific formulations, devices, or chemical compounds used in therapy.
3. Can naturally occurring substances be patented in Brazil?
Natural substances per se are not patentable unless significantly modified or processed to create a new, inventive composition or application.
4. How does the patent landscape influence drug innovation strategies in Brazil?
Stakeholders pursue patents that balance broad claims to deter competitors, specific claims for enforceability, and strategic filings across jurisdictions to maximize market exclusivity.
5. What should inventors consider when drafting patents like BRPI0719828?
They should ensure claims are clear, supported by detailed descriptions, navigate legal exclusions carefully, and align claims with international patent strategies to maximize protection.
References
[1] INPI. Brazilian Industrial Property Law (Law No. 9,279/1996).
[2] Brazilian Patent Examination Guidelines. INPI.
[3] World Intellectual Property Organization (WIPO). Patent Law Treaty.
[4] Johnson, R. “Strategic Patent Filing in Latin America.” Intellectual Property Journal, 2021.
[5] Silva, M. et al. Pharmaceutical Patent Strategies in Brazil. São Paulo: Pharma Publishing, 2019.
Disclaimer: This analysis is provided for informational purposes and does not constitute legal advice. For specific patent strategies or legal concerns, consult a qualified patent attorney familiar with Brazilian intellectual property law.
